Navigation Links
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
Date:6/17/2013

NEW BRUNSWICK, N.J., June 17, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today a definitive agreement to acquire Aragon Pharmaceuticals, Inc., a privately-held, pharmaceutical discovery and development company focused on drugs to treat hormonally-driven cancers.

The acquisition includes Aragon's androgen receptor antagonist program.  Aragon's lead product candidate is a second generation androgen receptor signaling inhibitor, ARN-509, in Phase 2 development for castration resistant prostate cancer (CRPC).

Under the terms of the agreement, Johnson & Johnson will make an upfront cash payment of $650 million, plus additional contingent payments of up to $350 million based on reaching predetermined milestones.  The transaction is expected to close in the third quarter of 2013. 

Prior to closing, Aragon will transfer all assets other than its androgen receptor antagonist program to a newly formed company, which Aragon will spin off.  Johnson & Johnson will not have an ownership stake in the new company nor retain any rights to these products or programs.

The closing is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, Aragon's consummation of the spin-off of the newly created company, and other customary closing conditions.  The boards of directors of both Johnson & Johnson and Aragon have approved the transaction.

"The acquisition of Aragon further enhances our leadership in prostate cancer drug development.  ARN-509 complements ZYTIGA® and provides the potential for exciting, novel approaches to treat prostate cancer patients," said Peter F. Lebowitz, M.D., Ph.D., Global Therapeutic Area Head, Oncology for Janssen Research & Development, LLC.  "Prostate cancer is one of our main areas of foc
'/>"/>

SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
2. Johnson & Johnson Expects to Incur Special Charge in Second Quarter for Previously Disclosed Legal Matters
3. N.J. Woman Sues Johnson & Johnsons Ethicon Unit Over Vaginal Mesh Injuries, Says The Lanier Law Firm
4. Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
5. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
6. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
7. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson Health Tech Statement on Lance Armstrong
10. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
11. Johnson & Johnson Announces Plans to Establish Innovation Centers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , August 27, 2014 ... Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current ... by MarketsandMarkets, the global Dental Equipment Market is expected ... million in 2014, growing at a CAGR of ... 95 market data tables and 61 figures spread ...
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Heart Valve Repair and ... About Heart Valve Repair and ... heart which control the flow of blood during ... valve diseases such as valvular stenosis, valvular insufficiency ...
(Date:8/27/2014)... 2014  Hill-Rom Holdings, Inc. (NYSE: HRC ... at the Morgan Stanley Global Healthcare Conference on September ... are invited to listen to the live discussion via ... it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay ... conclusion of the live event and accessible at the ...
Breaking Medicine Technology:Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3Global Heart Valve Repair and Replacement Market 2014-2018 2Global Heart Valve Repair and Replacement Market 2014-2018 3Global Heart Valve Repair and Replacement Market 2014-2018 4
... UNION CITY, Calif., Feb. 24, 2012  Abaxis, Inc. (NasdaqGS: ... systems, announced today that Clint Severson, chairman and chief ... Health Care Conference and the RBC Capital Markets, 2012 ... scheduled for Monday, February 27, 2012 at 11:30 a.m. ...
... Event details: February 25, 2012 ... Palm Springs Hotel Catalina/Madera Room ... Ameritox(SM), the nation,s leader in pain medication monitoring , will sponsor ... at the American Academy of Pain Medicine,s (AAPM) 28th Annual Meeting in Palm ...
Cached Medicine Technology:Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 2Abaxis, Inc. to Present at the Citi 2012 Global Health Care Conference and RBC Capital Markets' 2012 Healthcare Conference 3Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion 2Ameritox Provides Educational Support to Clinicians to Help Reduce Opioid Misuse, Abuse and Diversion 3
(Date:8/27/2014)... What’s next for 14 year old ... Scripps National Spelling Bee? Sririam will visit Philadelphia on ... renowned Wills Eye Hospital.     , The teen from Painted ... one day. , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller ... hi-tech visual diagnostic testing. He will also tour ...
(Date:8/27/2014)... Norton HealthDay Reporter , TUESDAY, ... in clinical trials of new heart disease treatments are generally ... study confirms. Experts said the findings, which appear in ... , aren,t surprising -- but they are troubling. "It,s ... select patient population that is not fully representative of the ...
(Date:8/27/2014)... Tejal K. Gandhi, MD, MPH, CPPS, president of the ... Lucian Leape Institute, is among the 100 Most Influential People ... Healthcare magazine. Also on the list are NPSF board members ... NPSF Lucian Leape Institute members Carolyn Clancy, MD; Bob Wachter, ... both the Institute and the NPSF Board of Directors. , ...
(Date:8/27/2014)... Germantown, Md., and Denver (PRWEB) August 27, 2014 ... estate developer , has broken ground on a 79,491 ... Holy Cross Health hospital campus in Germantown, an unincorporated ... Germantown is the third most populous place in Maryland, ... on the Holy Cross Germantown Hospital campus is one ...
(Date:8/27/2014)... jaundice: It,s one of the last things a parent ... condition in babies less than a week old. , ... that a newborn is jaundiced and isn,t adequately eliminating ... to see, and severe jaundice left untreated can harm ... have developed a smartphone application that checks for jaundice ...
Breaking Medicine News(10 mins):Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:NPSF President Among 100 Most Influential in Health Care 2Health News:NPSF President Among 100 Most Influential in Health Care 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 2Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 3Health News:NexCore Breaks Ground on Medical Office Building on Holy Cross Health Campus in Germantown, Maryland 4Health News:New smartphone app can detect newborn jaundice in minutes 2Health News:New smartphone app can detect newborn jaundice in minutes 3
... ultrasound to visualise organs and other internal structures of ... a computer model that can predict the sound transmission ... is capable of processing large quantities of data and ... parallel supercomputer. Erasmus University Medical Centre and Oldelft Ultrasound ...
... Hospira, Inc.,(NYSE: HSP ), a global specialty ... B. Begley, chairman and chief,executive officer, and Thomas ... officer, will make a formal presentation at the ... Nov. 12, 2008, in,Phoenix., The presentation is ...
... first-ever study of its kind, a team led ... Harbor-UCLA Medical Center (LA BioMed) report in November,s ... to respond to medication for depression and were less ... Using data from the nation,s largest real-world clinical study ...
... Day statement by,SEIU President Andy Stern:, "Paula Hall ... home and all her savings when she got sick ... "Samara Knight -- a nursing assistant from Cleveland, ... payments and the,medication her son needs -- will vote ...
... by nearly 100%, operating loss reduced by 44%, ... ), a leading provider of quantitative imaging for clinical,trials, ... 2008 were,over $1.8 million, a 33% increase over prior ... 30, 2008 were approximately $5.2,million compared to nearly $4.2 ...
... today announced that the company will report financial results ... fiscal year ending April,24, 2009 on Wednesday, November 19, ... conference call to discuss those results on Thursday, November,20, ... Second Quarter Results Conference Call Instructions, To listen ...
Cached Medicine News:Health News:Response rates to antidepressants differ among English- and Spanish-speaking Hispanics 2Health News:Today We Must Be the Change We Need 2Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 2Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 3Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 4Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 5Health News:VirtualScopics Reports Record Third Quarter 2008 Revenue and Gross Profit 6Health News:Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results 2
... practitioners consider the HOPE nebulizer the gold standard ... made to put everything together in one convenient ... is our #11320 Adult HOPE Kit which contains ... and pediatric aerosol mask all in one set ...
... offer a spill-proof design and effective output, ... angle. All medical nebulizers are free-standing for ... configurations are available., ,All Portex® medication ... medication nebulizers feature consistently fine misting and ...
... Portex® medication nebulizers offer a spill-proof ... up to a 45° angle. All medical ... ,A wide variety of configurations are available., ... latex-free. , ,Portex® medication nebulizers feature ...
... nebulizers offer a spill-proof design and effective ... 45° angle. All medical nebulizers are free-standing ... of configurations are available., ,All Portex® ... ,Portex® medication nebulizers feature consistently fine misting ...
Medicine Products: